(Total Views: 490)
Posted On: 09/27/2019 7:43:41 AM
Post# of 154909
This is why I question FDA motives sometimes ..
Grrr
They could approve already combo and mono , they have enough of data .,
let company have earning , and continue studies with different doses ...
Patients will benefit , company will benefit , shareholders will benefit ..
IMO only
Grrr
They could approve already combo and mono , they have enough of data .,
let company have earning , and continue studies with different doses ...
Patients will benefit , company will benefit , shareholders will benefit ..
IMO only
(0)
(0)
